These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25982601)

  • 21. Photocoagulation of diabetic macular oedema--complications and visual outcome.
    Lövestam-Adrian M; Agardh E
    Acta Ophthalmol Scand; 2000 Dec; 78(6):667-71. PubMed ID: 11167229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Apushkin MA; Fishman GA
    Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
    Lee CM; Olk RJ; Akduman L
    Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
    Tunc M; Onder HI; Kaya M
    Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
    Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New perspectives in the approach to diabetic macular edema. Aflibercept therapy].
    Ruiz-Moreno JM
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():24-8. PubMed ID: 25925048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teleophthalmology image-based navigated retinal laser therapy for diabetic macular edema: a concept of retinal telephotocoagulation.
    Kozak I; Payne JF; Schatz P; Al-Kahtani E; Winkler M
    Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1509-1513. PubMed ID: 28447201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic macular edema. A review.
    Bresnick GH
    Ophthalmology; 1986 Jul; 93(7):989-97. PubMed ID: 3531959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):766-85. PubMed ID: 2062512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
    Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M
    Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
    Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
    Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthreshold micropulse diode laser treatment in diabetic macular oedema.
    Laursen ML; Moeller F; Sander B; Sjoelie AK
    Br J Ophthalmol; 2004 Sep; 88(9):1173-9. PubMed ID: 15317711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Features associated with retinal thickness extension in diabetic macular oedema].
    Razo Blanco-Hernández DM; Lima-Gómez V; García-Rubio YZ
    Cir Cir; 2015; 83(3):183-7. PubMed ID: 26051929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
    Ockrim ZK; Sivaprasad S; Falk S; Roghani S; Bunce C; Gregor Z; Hykin P
    Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.